ETF Holdings Breakdown of UTHR

Stock NameUnited Therapeutics Corporation
TickerUTHR(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS91307C1027
LEI5299005C4HZL4UWROC14

News associated with UTHR

United Therapeutics Corporation (NASDAQ:UTHR) Holdings Cut by Trust Point Inc.
Trust Point Inc. lowered its stake in shares of United Therapeutics Corporation (NASDAQ:UTHR – Free Report) by 28.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,217 shares of the biotechnology company’s stock after selling 480 shares during the period. Trust Point Inc.’s […] - 2025-06-18 09:40:53
Sound Income Strategies LLC Makes New Investment in United Therapeutics Corporation (NASDAQ:UTHR)
Sound Income Strategies LLC bought a new position in shares of United Therapeutics Corporation (NASDAQ:UTHR – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 159 shares of the biotechnology company’s stock, valued at approximately $49,000. A number of […] - 2025-06-18 08:08:54
Pallas Capital Advisors LLC Has $351,000 Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)
Pallas Capital Advisors LLC lessened its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 36.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,140 shares of the biotechnology company’s stock after selling 652 shares during the period. Pallas Capital […] - 2025-06-13 07:54:53
United Therapeutics (NASDAQ:UTHR) Given New $315.00 Price Target at Bank of America
United Therapeutics (NASDAQ:UTHR – Get Free Report) had its price target reduced by analysts at Bank of America from $321.00 to $315.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the biotechnology company’s stock. Bank of America‘s price target indicates a potential upside of 10.09% from the company’s […] - 2025-06-13 05:19:03
United Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by UMB Bank n.a.
UMB Bank n.a. increased its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 17.1% during the first quarter, Holdings Channel reports. The fund owned 1,289 shares of the biotechnology company’s stock after purchasing an additional 188 shares during the quarter. UMB Bank n.a.’s holdings in United Therapeutics were worth $397,000 as of its […] - 2025-06-11 08:24:52
Wealth Enhancement Advisory Services LLC Raises Holdings in United Therapeutics Co. (NASDAQ:UTHR)
Wealth Enhancement Advisory Services LLC lifted its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 15.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 5,643 shares of the biotechnology company’s stock after acquiring an additional 769 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in United Therapeutics were […] - 2025-06-06 08:32:52
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Mackenzie Financial Corp
Mackenzie Financial Corp reduced its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 6.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,657 shares of the biotechnology company’s stock after selling 191 shares during the quarter. Mackenzie Financial Corp’s holdings in United […] - 2025-06-02 09:17:05
United Therapeutics Co. (NASDAQ:UTHR) EVP Sells $3,476,770.00 in Stock
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 11,000 shares of United Therapeutics stock in a transaction on Thursday, May 29th. The shares were sold at an average price of $316.07, for a total value of $3,476,770.00. Following the completion of the sale, the executive vice president now directly owns […] - 2025-06-02 08:29:03
State of Wyoming Acquires Shares of 177 United Therapeutics Co. (NASDAQ:UTHR)
State of Wyoming acquired a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 177 shares of the biotechnology company’s stock, valued at approximately $62,000. A number of other hedge funds […] - 2025-05-29 07:50:53
Focus Partners Wealth Increases Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
Focus Partners Wealth increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 127.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,917 shares of the biotechnology company’s stock after buying an additional 1,073 shares during the period. Focus Partners […] - 2025-05-20 07:54:58
United Therapeutics (NASDAQ:UTHR) Earns “Buy” Rating from HC Wainwright
United Therapeutics (NASDAQ:UTHR – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They currently have a $425.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price suggests a potential upside of 44.06% from the stock’s previous close. HC Wainwright […] - 2025-05-07 05:22:52
United Therapeutics (NASDAQ:UTHR) Cut to Buy at StockNews.com
StockNews.com lowered shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Friday morning. Several other brokerages also recently issued reports on UTHR. Morgan Stanley upped their price target on United Therapeutics from $346.00 to $348.00 and gave the stock an […] - 2025-05-05 05:28:51
United Therapeutics (NASDAQ:UTHR) Shares Gap Up After Better-Than-Expected Earnings
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $300.76, but opened at $317.10. United Therapeutics shares last traded at $298.77, with a volume of 87,993 shares changing hands. The biotechnology […] - 2025-05-02 05:10:54
United Therapeutics (NASDAQ:UTHR) Stock Rating Upgraded by Bank of America
United Therapeutics (NASDAQ:UTHR – Get Free Report) was upgraded by investment analysts at Bank of America from an “underperform” rating to a “neutral” rating in a note issued to investors on Monday, Marketbeat Ratings reports. The firm currently has a $314.00 price target on the biotechnology company’s stock. Bank of America‘s target price points to […] - 2025-04-23 05:10:56
Raymond James Financial Inc. Takes Position in United Therapeutics Co. (NASDAQ:UTHR)
Raymond James Financial Inc. purchased a new position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,744 shares of the biotechnology company’s stock, valued at approximately $18,257,000. A number of other […] - 2025-04-21 07:40:49
Envestnet Asset Management Inc. Grows Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)
Envestnet Asset Management Inc. boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 5.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 60,880 shares of the biotechnology company’s stock after buying an additional 2,889 shares during the quarter. Envestnet Asset […] - 2025-04-15 08:14:52
Cerity Partners LLC Buys 2,702 Shares of United Therapeutics Co. (NASDAQ:UTHR)
Cerity Partners LLC grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 30.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,588 shares of the biotechnology company’s stock after purchasing an additional 2,702 shares during the quarter. Cerity […] - 2025-04-14 10:32:44
Federated Hermes Inc. Increases Position in United Therapeutics Co. (NASDAQ:UTHR)
Federated Hermes Inc. lifted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,078 shares of the biotechnology company’s stock after buying an additional 305 shares during the quarter. Federated Hermes […] - 2025-04-14 09:54:56
Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) EVP Sells $3,367,980.00 in Stock
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 11,000 shares of the stock in a transaction on Thursday, April 3rd. The shares were sold at an average price of $306.18, for a total value of $3,367,980.00. Following the sale, the executive vice president now owns 36,781 shares in the company, […] - 2025-04-10 08:12:55
Raymond Dwek Sells 4,000 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) Director Raymond Dwek sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $284.55, for a total value of $1,138,200.00. Following the completion of the transaction, the director now owns 1,750 shares […] - 2025-04-10 08:12:54
United Therapeutics Co. (NASDAQ:UTHR) Given Average Rating of “Moderate Buy” by Brokerages
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twelve ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a […] - 2025-04-09 06:08:53
Korea Investment CORP Increases Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
Korea Investment CORP grew its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 6.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 39,289 shares of the biotechnology company’s stock after buying an additional 2,300 shares during the quarter. Korea Investment CORP’s holdings in United Therapeutics were worth $13,863,000 at the […] - 2025-03-31 10:40:53
United Therapeutics Co. (NASDAQ:UTHR) Stock Position Raised by Envestnet Portfolio Solutions Inc.
Envestnet Portfolio Solutions Inc. boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 8.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,082 shares of the biotechnology company’s stock after acquiring an additional 81 shares during the period. Envestnet […] - 2025-03-27 09:14:51
Commonwealth Equity Services LLC Acquires 301 Shares of United Therapeutics Co. (NASDAQ:UTHR)
Commonwealth Equity Services LLC increased its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 3.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,526 shares of the biotechnology company’s stock after buying an additional 301 shares during the quarter. […] - 2025-03-26 08:35:07
M&T Bank Corp Has $1.21 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
M&T Bank Corp increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 9.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,429 shares of the biotechnology company’s stock after buying an additional 294 shares […] - 2025-03-11 09:34:53
IFP Advisors Inc Trims Holdings in United Therapeutics Co. (NASDAQ:UTHR)
IFP Advisors Inc lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 18.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 855 shares of the biotechnology company’s stock after selling 194 shares during the period. […] - 2025-03-03 09:00:52
Global Retirement Partners LLC Increases Holdings in United Therapeutics Co. (NASDAQ:UTHR)
Global Retirement Partners LLC raised its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 38.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 596 shares of the biotechnology company’s stock after purchasing an additional 164 shares during the period. Global Retirement Partners LLC’s holdings in United Therapeutics were worth $210,000 as […] - 2025-02-26 09:54:53
Blue Trust Inc. Cuts Position in United Therapeutics Co. (NASDAQ:UTHR)
Blue Trust Inc. lowered its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 18.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,149 shares of the biotechnology company’s stock after selling 256 shares during the quarter. Blue Trust Inc.’s […] - 2025-02-18 11:06:55
Chevy Chase Trust Holdings LLC Reduces Stake in United Therapeutics Co. (NASDAQ:UTHR)
Chevy Chase Trust Holdings LLC reduced its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,726 shares of the biotechnology company’s stock after selling 323 shares during the period. […] - 2025-02-18 08:42:54
Bleakley Financial Group LLC Purchases 389 Shares of United Therapeutics Co. (NASDAQ:UTHR)
Bleakley Financial Group LLC increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 58.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,059 shares of the biotechnology company’s stock after purchasing an additional 389 shares during the […] - 2025-02-11 08:56:58

UTHR institutional holdings

The following institutional investment holdings of UTHR have been identified

Date ETF ISIN/Name Num Shares Book value
2025-06-23 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 64,240USD 18,397,694
2025-06-23 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 64,240USD 18,397,694 -1.5%
2025-06-23 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 64,240USD 18,397,694
2025-06-23 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 64,240USD 18,397,694
2025-06-23 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 5,458USD 1,563,117 -1.5%
2025-06-23 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 13,410USD 3,840,490 -1.5%
2025-06-23 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 12,520USD 3,585,603
2025-06-23 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 12,520USD 3,585,603
2025-06-23 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 12,520USD 3,585,603
2025-06-23 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 4,670 -0.2%USD 1,337,441 -1.7%
2025-06-23 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 1,221USD 349,682
2025-06-23 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 1,221USD 349,682
2025-06-23 IE00BP3QZB59 (iShares Edge MSCI World Value Factor UCITS ETF) 9,340USD 2,674,883
2025-06-23 IE00BFYTYS33 (iShares Edge MSCI World Value Factor UCITS USD Dist) 9,340USD 2,674,883 -1.5%
2025-06-23 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 3,358USD 961,698
2025-06-23 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 3,358USD 961,698
2025-06-23 IE00B8FHGS14 (iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc)) 32,225USD 9,228,918
2025-06-23 IE00BGPP8L80 (iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)) 32,225USD 9,228,918
2025-06-23 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 2,690USD 668,132 -1.7%
2025-06-23 IE00BD1F4M44 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Acc) GBP) 11,995USD 3,435,248
2025-06-23 IE00BFF5RX68 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)) 11,995USD 3,435,248
2025-05-29 IE00BP3QZ825 (iShares Edge MSCI World Momentum Factor UCITS ETF) 6,941USD 2,223,688 1.5%
2025-06-23 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 1,703USD 487,722
2025-06-23 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 1,012USD 289,827
2025-06-23 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 863USD 247,155
2025-06-23 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 863USD 247,155
2025-01-20 IE00BZ0PKT83 (iShares Edge MSCI World Multifactor UCITS ETF USD (Acc) GBP) 1,934USD 694,171
2025-01-20 IE00BYXPXK00 (iShares STOXX World Equity Multifactor UCITS ETF EUR Hedged (Acc)) 1,934USD 694,171
2025-06-23 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 22,355USD 6,402,248
2025-06-23 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 22,355USD 6,402,248
2025-05-29 IE00BD1F4N50 (iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Acc) GBP) 2,881 -1.2%USD 922,986 0.2%
2025-05-29 IE00BFF5RZ82 (iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)) 2,881 -1.2%USD 922,986 0.2%
2024-11-12 IE000OKVTDF7 (iShares MSCI USA Value Factor ESG UCITS ETF USD (Acc)) 3,029USD 1,214,235
2025-06-23 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 225USD 47,772
2025-06-23 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 1,270USD 363,715
2025-06-23 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 3,256USD 932,486
2025-01-20 IE00BZ0PKS76 (iShares STOXX USA Equity Multifactor UCITS ETF USD (Acc)) 276USD 99,065
2025-01-20 IE00BG13YZ23 (iShares Edge MSCI USA Multifactor UCITS ETF USD (Dist)) 276USD 99,065
2025-06-23 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 336USD 96,227
2025-06-23 IE000F9IDGB5 (iShares MSCI World Swap UCITS ETF USD (Acc)) 4,973USD 1,424,217
2025-05-29 IE0002PA3YE5 (iShares MSCI USA Momentum Factor ESG UCITS ETF USD (Acc)) 37USD 11,854 1.5%
2025-06-23 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 13,410USD 3,840,490 -1.5%
2025-06-23 IE0009VWHAE6 (iShares US Equity Enhanced Active UCITS ETF USD (Acc)) 1,901USD 544,427
2024-11-08 IE000X08RX14 (iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc)) 1,127USD 462,070 1.8%
2024-10-22 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 6,682 200.0%USD 2,474,077 200.1%
2024-10-22 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 6,682 200.0%USD 2,474,077 200.1%
2025-06-23 IE0002W8NB38 (iShares MSCI USA Swap UCITS ETF USD (Acc)) 5,116USD 1,465,171
2025-06-23 IE000WHL2ZK1 (iShares U.S. Equity High Income UCITS ETF USD Inc) 343USD 98,232 -1.5%
2025-06-23 IE000KJPDY61 (iShares World Equity High Income UCITS ETF USD Inc) 136USD 38,949
2025-06-23 IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc)) 184USD 52,696
2025-06-23 IE00BP3QZ601 (iShares Edge MSCI World Quality Factor UCITS ETF) 3,986USD 1,141,551
Total =555,993 USD 161,472,356
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.